Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-27
2006-06-27
Turner, Sharon (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07067473
ABSTRACT:
There is disclosed an isolated nucleic acid molecule encoding a human neurotrophic growth factor designated enovin and having the amino acid sequence illustrated in FIG.1, 21, 23or24or encoding a functional equivalent, derivative or bioprecursor of said growth factor. The growth factor preferably comprises the amino acid sequence from position 27 to 139 of the sequence illustrated in FIG.1, or a functional equivalent, derivative or bioprecursor thereof. The nucleic acid molecule encoding enovin can be used to transform a host cell, tissue or organism by including it in an appropriate vector. The host cell, tissue or organism and the vector also form part of the invention.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5739307 (1998-04-01), Johnson, Jr. et al.
patent: 5747655 (1998-05-01), Johnson, Jr. et al.
patent: 6284540 (2001-09-01), Milbrandt et al.
patent: 6593133 (2003-07-01), Johansen et al.
patent: 2004/0043927 (2004-03-01), Baker et al.
patent: WO 00/17360 (2000-03-01), None
patent: WO 00/18799 (2000-06-01), None
patent: WO 00/34475 (2000-06-01), None
Skolnick et al., Trends in Biotech., 18(1):34-39, 2000.
Jobling et al., Mol. Micro., 5(7):1755-67, 1991.
Baloh et al., Neuron, 21:1291-1302, Dec. 1998.
Lin et al., Science 260:1130-1302, May 1993.
Vukicevic et al., 1996, PNAS USA 93:9021-9026.
Choh, PNAS 77(6):3211-14, 1990.
Skolnick et al., Trends in Bioscience 18(1):34-39, 2000.
GenBank Accession No. AC005038.
Janssen Pharmaceutica N.V.
Turner Sharon
LandOfFree
Neurotrophic growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurotrophic growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotrophic growth factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663669